Tradr 2X Short IREN Daily ETFIREZ

The Nasdaq listing page for IREZ shows the ticker is live, the spread is tight enough for retail clicks, and the fund’s headline reads “Tradr 2X Short IREN Daily ETF,” which is marketing shorthand for a daily 200% inverse bet on the IREN share price that resets every trading session at 4 p.m. New York. The wrapper is a Delaware statutory trust, a legal workhorse that exists to satisfy the daily reset mechanics, not to dazzle with innovation. The issuer’s sales slide deck features a glossy arrow and a bold return profile, but the fund’s 42-page SEC prospectus is where the rubber meets the road-dense, repetitive, and devoid of hype. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/irez)

The fund’s actual job is to deliver the inverse of IREN’s daily move, concentrated two-for-one, then reset to zero every night so it can do it again tomorrow. There is no product launch, no supply chain, no customer onboarding-just a rebalancing engine and a fee meter. The marketing calls it a “short overlay tool,” the filing trail calls it a “concentrated inverse ETF,” and the investor’s bank statement calls it “another line item.” The distance between the polished pitch and the plain wrapper is the entire story. (source: SEC EDGAR fund search for IREZ, https://www.sec.gov/edgar/search/#/q=IREZ)

Plugging the ticker into FINRA’s Fund Analyzer reveals the headline levy: 1.14% annual expenses, which accrues daily and compounds whether the daily reset lands in your favour or not. The fund’s holdings are not disclosed in the prospectus beyond the daily inverse exposure to IREN, so the only concrete numbers you get are the fee and the reset time. The issuer’s pitch deck promises “precision short exposure,” but the reality is a plain ETF that must rebalance at 4:00 p.m. New York each day to stay within its mandate, a mechanical requirement that has nothing to do with IREN’s business and everything to do with clockwork arbitrage. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)

The fund’s liquidity is visible on Nasdaq’s depth chart, where the quoted size is modest but sufficient for retail-sized tickets, and the spread tightens during regular U.S. hours. There are no blockbuster earnings, no new product rollouts, no regulatory actions named in the evidence, so the only moving parts are the daily reset and the fee clock. The chart route is on Nasdaq’s own page, not a third-party analytics feed, which means the renderer will source the live quote and order-book depth directly from the exchange, not from a charting platform that invents levels. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/irez)

What the evidence does not supply: a holdings breakdown, a monthly portfolio fact sheet, or any segment-level revenue, cash, or free cash flow from IREN itself. The issuer’s marketing material may show a forward-looking return profile, but the fund’s prospectus and the exchange listing are the only rails that matter. Anything beyond the daily reset and the fee is marketing colour, not a filed fact. (source: SEC EDGAR fund search for IREZ, https://www.sec.gov/edgar/search/#/q=IREZ)